
XBI Technical Analysis Summary (AMEX)
Analyze XBI on the AMEX with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerXBI Technical Analysis Summary (AMEX)
State Street SPDR S&P Biotech ETF (AMEX: XBI) stock currently shows a neutral trend on the AMEX, supported by momentum and balanced buying pressure.
Technical conditions suggest State Street SPDR S&P Biotech ETF on the AMEX is awaiting a decisive move. Technical conditions suggest State Street SPDR S&P Biotech ETF is consolidating, awaiting a decisive move.
RSI (14): 45.36
Stochastic %K: 24.50
Williams %R: -73.46
Rate of Change (ROC): -3.54
Takeaway:State Street SPDR S&P Biotech ETF shows weakening momentum, with sellers gaining the edge.
MACD: -0.80
ADX: 17.08
ATR (14): 4.07
CCI (14): -54.45
Takeaway:State Street SPDR S&P Biotech ETF shows a neutral trend, with weak conviction and limited volatility.
Takeaway:State Street SPDR S&P Biotech ETF trades closer to support, showing weaker momentum within bands.
Takeaway:State Street SPDR S&P Biotech ETF trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:XBI shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for State Street SPDR S&P Biotech ETF are mixed, suggesting a Hold or wait-and-see approach.